Binding of endogenous GLP-1 to β cell GLP-1Rs potentiates postprandial insulin secretion, with pharmacological agonists successfully leveraging this effect to control blood glucose levels in people with T2D (1). This evidence concerns the gene GCG and type 2 diabetes mellitus.